Neuronal damage and cognitive impairment associated with hypoglycemia: An integrated view

Neurochemistry International

Volumn 63, Issue 4, 2013, Pages 331-343

  Languren, Gabriela ^a   Montiel, Teresa ^a   Julio Amilpas, Alberto ^a   Massieu, Lourdes ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cognitive impairment; Excitotoxicity; Hypoglycemia; Insulin; Oxidative stress; Selective neuronal death

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; ADRENALIN; CARBOHYDRATE; GLUCAGON; GLUCOSE; INSULIN; KETONE BODY; LACTIC ACID; NORADRENALIN; PYRUVIC ACID; SHORT ACTING INSULIN; STREPTOZOCIN; SULFONYLUREA;

ADRENAL MEDULLA; ANTEROGRADE AMNESIA; ANTIOXIDANT ACTIVITY; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; BLURRED VISION; BRAIN CORTEX; BRAIN DAMAGE; CANADA; CAUDATE NUCLEUS; CELL DAMAGE; COGNITIVE DEFECT; CONCENTRATION (PARAMETERS); CONFUSION; CONSCIOUSNESS; DENMARK; DENTATE GYRUS; DIABETIC PATIENT; DISEASE DURATION; DIZZINESS; DROWSINESS; EMERGENCY WARD; EXCITOTOXICITY; GLUCAGON RELEASE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; GLUCOSE INFUSION; GLUCOSE INTAKE; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; GLYCOGENOLYSIS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HISTOLOGY; HOSPITAL ADMISSION; HUMAN; HYPERPOLARIZATION; HYPOGLYCEMIA; HYPOGLYCEMIC COMA; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN RELEASE; IRRITABILITY; LIPID PEROXIDATION; LONG TERM EXPOSURE; LONG TERM POTENTIATION; MENTAL DETERIORATION; MITOCHONDRIAL MEMBRANE; MOTOR PERFORMANCE; NERVE CELL CULTURE; NERVE ENDING; NERVE INJURY; NEUROPSYCHOLOGICAL TEST; NOCTURNAL HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORTH AMERICA; OBSERVATIONAL STUDY; OLIGODENDROGLIA; OXIDATIVE STRESS; PANCREAS TRANSPLANTATION; PATIENT EDUCATION; PERIRHINAL CORTEX; PRIORITY JOURNAL; PYRIFORM CORTEX; REACTION TIME; RESPIRATORY CHAIN; REVIEW; RODENT MODEL; SEIZURE; SHORT TERM MEMORY; SPATIAL MEMORY; SWITZERLAND; SYNAPSE VESICLE; TREATMENT DURATION; UNITED KINGDOM; UNITED STATES; VERBAL MEMORY;

ANIMALIA;

COGNITIVE IMPAIRMENT; ET; ETHIDIUM; EXCITOTOXICITY; FJB; FLUOROJADE-B; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GPX; GR; GSH; GSSG; HYPOGLYCEMIA; INSULIN; MANGANESE-DEPENDENT SUPEROXIDE DISMUTASE; MNSOD; NADPH OXIDASE; NOX; OXIDATIVE STRESS; OXIDIZED GLUTATHIONE; PARP-1; POLY-(ADP RIBOSE) POLYMERASE-1; REACTIVE OXYGEN SPECIES; REDUCED GLUTATHIONE; ROS; SELECTIVE NEURONAL DEATH;

ANIMALS; COGNITION DISORDERS; HUMANS; HYPOGLYCEMIA; NEURONS;

EID: 84882523033     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.06.018     Document Type: Review

References (139)

1. Amiel, S., 1998. Cognitive function testing in studies of acute hypoglycaemia: rights and wrongs. Diabetología 41, 713-719. (Pubitemid 28261408)
2. Aoki, T., Sato, T., Hasegawa, K., Ishizaki, R., Saiki, M., 2004. Reversible hyperintensity lesion on diffusion-weighted MRI in hypoglycemic coma. Neurology 63, 392-393. (Pubitemid 38971155)
3. Attwell, D., Laughlin, S., 2001. An energy budget for signaling in the gray matter of the brain. J. Cereb. Blood Flow Metab. 21, 1133-1145. (Pubitemid 32947479)
4. Auer, R.N., Kalimo, H., Olsson, Y., Siesjö, B.K., 1985a. The temporal evolution of hypoglycemic brain damage. I. Light and - electron microscopic findings in the rat cerebral cortex. Acta Neuropathol. 67, 13-24. (Pubitemid 15021207)
5. Auer, R.N., Kalimo, H., Olsson, Y., Siesjö, B.K., 1985b. The temporal evolution of hypoglycemic brain damage. II. Light and electron microscopic findings in the hippocampal gyrus and subiculum of the rat. Acta Neuropathol. 67, 25-36. (Pubitemid 15021208)
6. Bakatselos, S., 2011. Hypoglycemia unawareness. Diabetes Res. Clin. Pract. 93, 92-96.
7. Beall, C., Ashford, M.L., McCrimmon, A., McCrimmon, R., 2012. The physiology and pathophysiology of the neural control of the counterregulatory response. Am. J. Physiol. Regul. Integr. Comp. Physiol. 202, 215-223.
8. Becker, D., Ryan, C., 2005. Hypoglycemia: a complication of diabetes therapy in children. Trends Endocrinol. Metab. 11, 198-202.
9. Bélanger, M., Allaman, I., Magistretti, P.J., 2011. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 14, 724-738.
10. Bhardwaj, S.K., Sharma, M.L., Gulati, G., Chhabra, A., Kaushik, R., Sharma, P., Kaur, G., 1998. Effects of starvation and insulin-induced hypoglycemia on oxidative stress scavenger system and electron transport chain complexes from the rat brain, liver and kidney. Mol. Chem. Neuropathol. 34, 157-168. (Pubitemid 29168576)
11. Birkeland, K., Home, P., Wendisch, U., et al., 2011. Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine. Diabetes Care 34, 661-665.
12. Blasetti, A., Chiuri, R., Tocco, A., Di Giulio, C., Mattei, P., Ballone, E., Chiarelli, F., Verrotti, A., 2011. The effect of recurrent severe hypoglycemia on cognitive performance in children with type 1 diabetes: a meta-analysis. J. Child Neurol. 26, 1383-1391.
13. Boland, E., Grey, M., Oesterle, A., Fredrickson, L., Tamborlane, W., 1999. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 22, 1779-1784. (Pubitemid 29521861)
14. Bree, A.J., Puente, E.C., Daphna-Iken, D., Fisher, S.J., 2009. Diabetes increases brain damage caused by severe hypoglycemia. Am. J. Physiol. Endocrinol. Metab. 297, 194-201.
15. Butcher, S.P., Jacobson, I., Sandberg, M., Hagberg, H., Hamberger, A., 1987a. 2-Amino-5-phosphonovalerate attenuates the severe hypoglycemia-induced loss of perforant path-evoked field potentials in the rat hippocampus. Neurosci. Lett. 76, 296-300. (Pubitemid 17070555)
16. Butcher, S.P., Sandberg, M., Hagberg, H., Hamberger, A., 1987b. Cellular origins of endogenous amino acids released into the extracellular fluid of the rat striatum during severe insulin-induced hypoglycemia. J. Neurochem. 48, 722-728. (Pubitemid 17018700)
17. Cardoso, S., Santos, M.S., Seica, R., Moreira, P.I., 2010. Cortical and hipocampal mitocondria bioenergetics and oxidative status during hyperglycemia and/or insulin-induced hypoglycemia. Biochim. Biophys. Acta 1802, 942-951.
18. Cardoso, S., Santos, R.X., Correia, S.C., Carvalho, C, Santos, M.S., Balderiras, I., Oliveira, CR., Moreira, P.I., 2012. Insulin-induced recurrent hypoglycemia exacerbates diabetic brain mitochondrial dysfunction and oxidative imbalance. Neurobiol. Dis. 49, 1-12.
19. Castle, J., Engle, J., Youssef, E., Massoud, R., Ward, W., 2010. Factors influencing the effectiveness of glucagon for preventing hypoglycemia. J. Diab. Sci. Technol. 6, 1305-1310.
20. Cryer, P.E., 2006. Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes. J. Clin. Invest. 116, 1470-1473.
21. Cryer, P.E., 2007. Hypoglycemia, functional brain failure, and brain death. J. Clin. Invest. 117, 868-870. (Pubitemid 46556741)
22. Cryer, P.E., Davis, S.N., Shamoon, H., 2003. Hypoglycemia in diabetes. Diabetes Care 26, 1902-1912. (Pubitemid 36929141)
23. De Galan, B.E., Schouwenberg, B., Tack, C, Smits, P., 2006. Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes. Neth. J. Med. 64, 269-279. (Pubitemid 44463710)
24. Desagher, S., Glowinski, J., Prémont, J., 1997. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 17, 9060-9067. (Pubitemid 27498433)
25. DeVries, J., Nattrass, M., Pieber, T., 2007. Refining basal insulin therapy: what have we learned in the age of analogues? Diabetes Metab. Res. Rev. 23, 441-454. (Pubitemid 47526934)
26. Diabetes Control and Complications Trial (DCCT), 2006. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes. Endocr. Pract. 12, 41-43.
27. Donnelly, L, Morris, A., Frier, B., Ellis§, J., Donnant, P., Durrant, R., Band, M., Reekie, G., Leese, G., 2005. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: A population-based study. Diabet. Med. 22, 749-755. (Pubitemid 40805897)
28. Draelos, M., Jacobson, A., Weinger, K., Widom, B., Ryan, C, Finckelstein, D., Simonson, D., 1995. Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. Am. J. Med. 98, 135-144.
29. El-Kathib, F., Russell, S., Nathan, D., Sutherlin, R., Damiano, E., 2010. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci. Transl. Med. 2, 1-12.
30. Ennis, K., Tran, P., Seaquist, E.R., Rao, R., 2008. Postnatal age influences hypoglycemia-induced neural injury in the rat brain. Brain Res. 1224, 119-126.
31. Evans, M.L., Pernet, A., Lomas, J., Jones, J., Amiel, S.A., 2000. Delay in onset of awareness of acute hypoglycemia and restoration of cognitive performance during recovery. Diabetes Care 23, 893-897. (Pubitemid 30480014)
32. Ewing, F.M.E., Deary, I.J., McCrimmon, R.J., Strachan, M.W.J., Frier, B., 1998. Effect of acute hypoglycemia on visual information processing in adults with type 1 diabetes mellitus. Physiol. Behav. 64, 653-660. (Pubitemid 28470582)
33. Fanelli, C, Epifano, L, Rambotti, A., 1993. Meticulous prevention of hypoglycaemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycaemia in intensively treated patients with short term IDDM. Diabetes 42, 1683-1689. (Pubitemid 23318128)
34. Fatourechi, M., Kudva, Y., Murad, M., Elamin, M., Tabini, C, Montori, V., 2009. Clinical review: hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J. Clin. Endocrinol. Metab. 94, 729-740.
35. Feltbower, R., Bodansky, H.J., Patterson, C, Parslow, R.C., Stephenson, CR., Reynolds, C, McKinney, P.A., 2008. Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results from the Yorkshire register of diabetes in children and young adults. Diabetes Care 31, 922-926.
36. Ferrand-Drake, M., Friberg, H., Wieloch, T., 1999. Mitochondrial permeability transition induced DNA-fragmentation in the rat hippocampus following hypoglycemia. Neuroscience 90, 1325-1338. (Pubitemid 29170148)
37. Ferrand-Drake, M., Zhu, C, Gidö, G., Hansen, A., Karlsson, J., Bahr, B., Zamzami, N., Kroemer, G., Chan, P., Wieloch, T., Blomgren, K., 2003. Cyclosporin A prevents calpain activation despite increased intracellular calcium concentrations, as well as translocation of apoptosis-inducing factor, cytochrome c and caspase-3 activation in neurons exposed to transient hypoglycemia. J. Neurochem. 85, 1431-1442. (Pubitemid 36702556)
38. Friberg, H., Ferrand-Drake, M., Bengtsson, F., Halestrap, A.P., Wieloch, T., 1998. Cyclosporin A, but not FK 506 protects mitochondria and neurons against hypoglycemic damage and implicates mitochondrial permeability transition in cell death. J. Neurosci. 18, 5151-5159. (Pubitemid 28311932)
39. Fujioka, M., Okuchi, K., Hiramatsu, K., Sakaki, T., Sakaguchi, S., Ishii, Y., 1997. Specific changes in human brain after hypoglycemic injury. Stroke 28, 584-587. (Pubitemid 27118381)
40. Gale, E., 2000. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with type 1 diabetes on intensified insulin therapy. The UK trial group. Diabet. Med. 3, 209-214. (Pubitemid 30212293)
41. García, O., Massieu, L., 2003. The glutamate uptake inhibitor, L-trans-pyrrolidine 2,4-pyrrolydine dicarboxylate, becomes neurotoxic in the presence of subthreshold concentrations of the mitochondrial toxin 3-nitropropionate. Involvement of mitochondrial reducing activity and ATP production. J. Neurosci. Res. 74, 956-966. (Pubitemid 37490429)
42. Geddes, J., Schopman, J., Zammitt, N., Frier, B., 2008. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet. Med. 25, 501-504. (Pubitemid 351490123)
43. Gold, A., Macleod, K., Deary, I., Frier, B.M., 1995. Hypoglycemia-induced cognitive dysfunction in diabetes mellitus: effect of hypoglycemia unawareness. Physiol. Behav. 58, 501-511.
44. Guemez-Gamboa, A., Estrada-Sánchez, A.M., Montiel, T., Páramo, B., Massieu, L., Morán, J., 2011. Activation of NOX2 by the stimulation of ionotropic and metabotropic glutamate receptors contributes to glutamate neurotoxicity in vivo through the production of reactive oxygen species and calpain activation. J. Neuropathol. Exp. Neurol. 70, 1020-1035.
45. Haces, M.L., Hernández-Fonseca, K., Medina-Campos, O.N., Montiel, T., Pedraza-Chaverri, J., Massieu, L., 2008. Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp. Neurol. 211, 85-96.
46. Haces, M.L., Montiel, T., Massieu, L., 2010. Selective vulnerability of brain regions to oxidative stress in a non-coma model of insulin-induced hypoglycemia. Neuroscience 165, 28-38.
47. Halliwell, B., 2006. Oxidative stress and neurodegeneration. Where are we now? J. Neurochem. 97, 1634-1658. (Pubitemid 43873658)
48. Hannonem, R., Tupola, S., Ahonen, T., Riikonen, R., 2003. Neurocognitive functioning in children with type 1 diabeteswith and without episodes of severe hypoglycemia. Dev. Med. Child Neurol. 45, 262-268. (Pubitemid 36372208)
49. Harris, R., Wieloch, T., Symon, L., Siesjo, B., 1984. Cerebral extracellular calcium activity in severe hypoglycemia: relation to extracellular potassium and energy state. J. Cereb. Blood Flow Metab. 2, 187-193. (Pubitemid 14080147)
50. Heller, S., Colagiuri, S., Vaaler, S., Wolffenbuttel§, K., Koelendorf, H., Friberg, K., Windfeld, K., Lindholm, A., 2004. Hypoglycaemia with insulin aspart: a doubleblind randomised, crossover trial in subjects with Type 1 diabetes. Diabet. Med. 21, 769-775. (Pubitemid 38916224)
51. Heller, S., Choudhary, P., Davies, C., Emery, C., Campbell, M.J., Freeman, J., Amiel, S.A., Malik, R., Frier, B.M., Allen, K., Zammitt, N., Macleod, K., Lonnen, K., Kerr, D., Richardson, T., Hunter, S., Mclaughlin, D., 2007. UK Hypoglycaemia study group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50, 1140-1147. (Pubitemid 46701541)
52. Heller, S., Buse, J., Fisher, M., Garg, S., Marre, M., Maerker, L., Renard, E., RussellJones, D., Philotheou, A., Ocampo, A., Pei, H., Bode, B., 2012. Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet 379, 1489-1497.
53. Hershey, T., Perantie, D., Warren, S.L., Zimmerman, E.C., Sadler, M., White, H.M., 2005. Frequency and timing of severe hypoglycaemia affects spatial memory in children with type 1 diabetes. Diabetes Care 28, 2372-2377. (Pubitemid 41384279)
54. Ho, M., Weller, N.J., Ives, F., Carne, C.L., Murray, K., Vanden Driessen, R., Nguyen, T., Robins, P.D., Bulsara, M., Davis, E.A., Jones, T.W., 2008. Prevalence of structural central nervous system abnormalities in early-onset type 1 diabetes mellitus. J. Pediatr. 153, 385-390.
55. Holmes, C., Koepke, K., Thompson, R., 1986. Simple versus complex performance impairments at three blood glucose levels. Psychoneuroendocrinology 11, 353-357. (Pubitemid 16002258)
56. Home, P.D., Fritsche, A., Schinzel, S., Massi-Benedetti, M., 2010. Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin gargline. Diabetes, Obesity and Metabolism 12, 772-779.
57. Hopkins, D., Korzon-Burakowsak, A., Lomas, J., 1997. Symptoms counterregulatory hormone responses and cognitive function during hypoglycaemia in NIDDM. Diabetologia 40, 27-31.
58. Izumi, Y., Benz, A.M., Katzuki, H., Zorumski, C.F., 1997. Endogenous monocarboxylates sustain hippocampal synaptic function and morphological integrity during energy deprivation. J. Neurosci. 17, 9448-9457. (Pubitemid 28006389)
59. *. N. Engl. J. Med. 356, 1842-1852.
60. Juge, N., Gray, J., Omote, H., Miyaji, T., Inoue, T., Hara, C., Uneyama, H., Robert, H., Roger, E., Nicoll, A., Moriyama, Y., 2010. Metabolic control of vesicular glutamate transport and release. Neuron 1, 99-112.
61. Kalimo, H., Olsson, Y., 1980. Effects of severe hypoglycemia on the human brain. Neuropathological case reports. Acta Neurol. Scand. 62, 345-356. (Pubitemid 11200540)
62. Kalimo, H., Auer, R.N., Siesjo, B.K., 1985. The temporal evolution of hypoglycemic brain damage. III. Light and electron microscopic findings in the rat caudado-putamen. Acta Neuropathol. 67, 37-50. (Pubitemid 15021209)
63. Kirchhoff, B., Lugar, H., Smith, S., Meyer, E., Perantie, D., Kolody, B., Koller, J., Arbelaez, A., Shimony, J., Hershey, T., 2013. Hypoglycaemia - induced changes in regional brain volume and memory function. Diabet. Med. 30, 151-156.
64. Lee, B., Jin, E., Hwang, H., Yoo, H., Jeong, J., 2010. A case of hypoglycemic brain injuries with cortical laminar necrosis. J. Korean Med. 25, 961-965.
65. Leese, G., Wang, J., Broomhall, J., Kelly, P., Mardsen, A., Morrison, W., Frier, B., Morris, A., 2003. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes. Diabetes Care 26, 1176-1180.
66. Leitao, C., Tharavanij, T., Cure, P., Pileggi, A., Baidal, D.A., Ricordi, C., Alejandro, R., 2008. Restoration of hypoglycemia awareness after islet transplantation. Diabetes Care 31, 2113-2115.
67. Lin, Y.Y., Hsu, C.W., Sheu, W., Chu, S., Wu, C., Tsai, S., 2010. Risk factors for recurrent hypoglycemia induced in hospitalized diabetic patients admitted for severe hypoglycemia. Yonsei Med. J. 51, 367-374.
68. Little, S., Shaw, J., Home, P., 2011. Hypoglycemia rates with basal insulin analogs. Diabetes Technol. Ther. 13, 53-64.
69. Ma, W., Berg, J., Yellen, G., 2007. Ketogenic diet metabolites reduce firing in central neurons by opening KATP channels. J. Neurosci. 14, 3618-3625. (Pubitemid 46557685)
70. Ma, J., Kim, Y., Yoo, W., Ihn, Y., Kim, J., Song, H., Kim, B., 2009. MR imaging of hypoglycemic encephalopathy: lesion distribution and prognosis prediction by diffusion-weighted imaging. Neuroradiology 10, 641-649.
71. Maran, A., Lomas, J., Macdonald, I.A., Amiel, S.A., 1995. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively treated - IDDM. Diabetologia 38, 1412-1418.
72. Maran, A., Crepaldi, C., Trupiani, S., 2000. Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and type 1 diabetic subjects. Diabetologia 43, 733-741. (Pubitemid 30409149)
73. Massieu, L., Gómez-Román, N., Montiel, T., 2000. In vivo potentiation of glutamate-mediated neuronal damage after chronic administration of the glycolysis inhibitor iodoacetate. Exp. Neurol. 165, 257-267.
74. Massieu, L., Del Río, P., Montiel, T., 2001. Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates. Neuroscience 106, 669-677. (Pubitemid 33000173)
75. Massieu, L., Haces, M.L., Montiel, T., Hernández-Fonseca, K., 2003. Acetoacetate protects hippocampal neurons against glutamate-induced neuronal damage during glycolysis inhibition. Neuroscience 120, 365-378. (Pubitemid 37288773)
76. Maxwell, L., McFarland, M., 2013. Clinical utility and tolerability of linagliptin in diabetic patients. Drug Health Patient Saf. 5, 67-78.
77. McGowan, J., Chen, L., Gao, D., Trush, M., Wei, C., 2006. Increased mitochondrial reactive oxygen species production in newborn brain during hypoglycemia. Neurosci. Lett. 399, 111-114.
78. McNay, E.C., Sherwin, R.S., 2004. Effect of recurrent hypoglycemia on spatial cognition and cognitive metabolism in normal and diabetic rats. Diabetes 53, 418-425. (Pubitemid 38174558)
79. McNay, E.C., Williamson, A., McCrimmon, R., Sherwin, R.S., 2006. Cognitive and neural hippocampal effects of long-term moderate recurrent hypoglycemia. Diabetes 55, 1088-1095. (Pubitemid 44100186)
80. Moore, H., Craft, T., Grimaldi, L.M., Badic, B., Brunelli, S.A., Vannucci, S.J., 2010. Moderate recurrent hypoglycemia during early development leads to persistent changes in affective behavior in the rat. Brain Behav. Immun. 24, 839-849.
81. Nehlig, A., Pereira de Vasconcelos, A., 1993. Glucose and ketone bodies utilization by the brain of neonatal rats. Prog. Neurobiol. 40, 163-221.
82. Nellgard, B., Wieloch, T., 1992. Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia. Exp. Brain Res. 92, 259-266. (Pubitemid 23018033)
83. Ouyang, Y., Ping He, Q., Zhang, X., Wang, G., Siesjo, B., Hu, B., 2000. Alteration of cyclic adenosine monophosphate response element binding protein in rat brain after hypoglycemic coma. J. Cereb. Blood Flow Metab. 20, 1550-1556.
84. Owen, O.E., Morgan, A.P., Kemp, H.G., Sullivan, J.M., Herrera, M.G., Cahill, G.F., 1967. Brain metabolism during fasting. J. Clin. Invest. 46, 1589-1595.
85. Page, K.A., Williamson, A., Yu, N., McNay, E.C., Dzuira, J., McCrimmon, R.J., Sherwin, R.S., 2009. Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes 58, 1237-1244.
86. Páramo, B., Hernández-Fonseca, K., Estrada-Sánchez, A., Jiménez, N., Hernández Cruz, A., Massieu, L., 2010. Pathways involved in the generation of reactive oxygen and nitrogen species during glucose deprivation and its role on the death of cultured hippocampal neurons. Neuroscience 167, 1057-1069.
87. Páramo, B., Montiel, T., Rivera-Martínez, M., Morán, J., Massieu, L., submitted for publication. Glucose deprivation-induced neuronal death involves calpain activation mediated by oxidative stress.
88. Park, M., Yoo, S., Choe, B., Dantzer, R., Freund, G., 2012. Acute hypoglycemia causes depressive-like behaviors in mice. Metab. Clin. Exp. 61, 229-236.
89. Patocková, J., Marhol, P., Tumova, E., Krsiak, M., Rokyta, R., Stípek, S., Crkovska, J., Andel, M., 2003. Oxidative stress in the brain tissue of laboratory mice with acute post insulin with hypoglycemia. Physiol. Res. 52, 131-135. (Pubitemid 36356271)
90. Patterson, C., Dahlquist, G., Harjutsalo, V., Joner, G., Feltbower, R.G., Svensson, J., Schoeber, E., Gyürüs, E., Castle, C., Urbonaité, B., Rosenbauer, J., Iotova, V., Thornsson, A., Soltész, A., 2007. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetología 50, 2439-2442. (Pubitemid 350060644)
91. Pedersen-Bjergaard, U., Pramming, S., Thorsteinsson, B., 2004. Recall of severe hypoglycaemia and self-stimated state of awareness in type 1 diabetes. Diabetes Metab. Res. Rev. 19, 232-240. (Pubitemid 36675964)
92. Pellerin, L., 2010. Food for thought: the importance of glucose and other energy substrates for sustaining brain function under varying levels of activity. Diabetes Metab. 36, 59-63.
93. Pellerin, L., Magistretti, P.J., 1994. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl. Acad. Sci. U.S.A. 91, 10625-10629. (Pubitemid 24329051)
94. Perantie, D., Lim, A., Wu, J., Weaver, P., Warren, S., Sadler, M., White, N., Hershey, T., 2008. Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediatr. Diabetes 9, 87-95. (Pubitemid 351560357)
95. Perros, P., Deary, I., Sellar, R., Best, J.J., Frier, B.M., 1997. Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20, 1013-1018. (Pubitemid 27224956)
96. Pickup, J., Freeman, S., Sutton, A., 2011. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self-monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ 7, 343-3805.
97. Pramming, S., Thorsteinsson, B., Bentson, I., Binder, C., 1991. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet. Med. 3, 217-222.
98. Puente, E.C., Silverstein, J., Bree, A.J., Musikantow, D.R., Wozniak, D.F., Maloney, S., Daphna-Iken, D., Fisher, S., 2010. Recurrent moderate hypoglycemia ameloriates brain damage and cognitive dysfunction induced by severe hypoglycemia. Diabetes 59, 1055-1062.
99. Rickels, M.R., 2012. Recovery of endocrine function after islet and pancreas transplantation. Curr. Diab. Rep. 5, 587-596.
100. Ryan, C., Atchison, J., Puczynski, S., Puczynski, M., Arslanian, S., Becker, D., 1990. Mild hypoglycaemia associated with deterioration of mental efficiency in children with insulin-dependent diabetes mellitus. J. Pediatr. 117, 32-38. (Pubitemid 20217490)
101. Sandberg, M., Nystrom, B., Hamberger, A., 1986. Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: In vivo dialysis of the rat hippocampus. J. Neurochem. 47, 178-184. (Pubitemid 16069188)
102. Schutz, P.W., Wong, P.K.H., O'Kusky, J., Innis, S.M., Stockler, S., 2011. Effects of D-3-hydroxybutyrate treatment on hypoglycemic coma in rat pups. Exp. Neurol. 227, 180-187.
103. Seaquist, E., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S., Rodríguez, H., Rosenzweig, J., Vigersky, R., 2013. Hypoglycemia and diabetes: a report of the workgroup of the american diabetes association and endocrinology society. Diabetes Care 36, 1384-1395.
104. Shety, P.K., Sadgrove, M.P., Galeffi, F., Turner, D.A., 2012. Pyruvate incubation enhances glycogen stores and susteain neuronal function during subsequent glucose deprivation. Neurobiol. Dis. 45, 177-187.
105. Siman, R., Noszek, C., Kegerise, C., 1989. Calpain 1 activation is specifically related to excitatory amino acid induction of hippocampal damage. J. Neurosci. 9, 1579-1590. (Pubitemid 19146254)
106. Simpson, I., Carruthers, A., Vannucci, S., 2007. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J. Cereb. Blood Flow Metab. 27, 1766-1791. (Pubitemid 47624552)
107. Simpson, I., Dwyer, D., Malide, D., Moley, K., Travis, A., Vanucci, S., 2008. The facilitative glucose transporter 3: twenty years of distinction. Am. J. Physiol. Endocrinol. Metab. 295, 242-253.
108. Singh, P., Jain, A., Kaur, G., 2004. Impact of hypoglycemia and diabetes on SNC: correlation of mitochondrial oxidative stress with DNA damage. Mol. Cell. Biochem. 260, 153-169.
109. Skrivarhaug, T., Bangstad, H., Stene, L., Sandvik, L., Hanssen, K., Joner, G., 2006. Longterm mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2, 298-305. (Pubitemid 43185398)
110. Sommerfield, A., Deary, I., McAulay, V., Frier, B., 2003. Short-term, delayed and working memory are impaired during hypoglycemia in individuals with type 1 diabetes. Diabetes Care 26, 390-396. (Pubitemid 36929061)
111. Stahl, M., Berger, W., 1999. Higher incidence of severe hypoglycaemia leading to hospital admission in type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas. Diabet. Med. 16, 586-590.
112. Steil, G., Rebrin, K., Darwin, C., Hariri, F., Saad, M.F., 2006. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 55, 3344-3350. (Pubitemid 44923591)
113. Strachan, M., Deary, I., Ewing, F., Frier, B., 2000. Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes. Diabetes Care 23, 305-312. (Pubitemid 30131735)
114. Suh, S., Aoyama, K., Chen, Y., Garnier, P., Matsumori, Y., Gum, E., Liu, J., Swanson, R., 2003. Hypoglycemic neuronal death and cognitive impairment are prevented by poly (ADP-Ribose) polymerase inhibitors administered after hypoglycemia. J. Neurosci. 23, 10681-10690. (Pubitemid 37485282)
115. Suh, S., Aoyama, K., Matsumori, Y., Liu, J., Swanson, R., 2005. Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment. Diabetes 54, 1452-1458. (Pubitemid 40586677)
116. Suh, S.W., Gum, E.T., Hamby, A.M., Chan, P.H., Swanson, R.A., 2007. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J. Clin. Invest. 117, 910-918. (Pubitemid 46556747)
117. Suh, S.W., Hamby, A.M., Gum, E.T., Shin, B.S., Won, S.H., Sheline, C.T., Chan, P.K., Swanson, R.A., 2008. Sequential release of nitric oxide, zinc and superoxide in hypoglycemic neuronal death. J. Cereb. Blood Flow Metab. 28, 1697-1706.
118. Tanner, G., Lutas, A., Martínez-Francois, J., Yellen, G., 2011. Single KATP channel opening in response to action potential firing in mouse dentate granule neurons. J. Neurosci. 31, 8689-8696.
119. Taylor, S.R., Harris, K.B., 2013. The clinical efficacy and safety of sodium glucose cotransporter-2 inhibitors in adults with type 2 diabetes mellitus. Pharmacotherapy. http://dx.doi.org/10.1002/phar.1303.
120. Tesfaye, N., Seaquist, E.R., 2010. Neuroendocrine responses to hypoglycemia. Ann. Acad. Sci. 1212, 12-28.
121. Tkacs, N.C., Dunn-Meynell, A., Levin, B., 2000. Presumed apoptosis and reduced arcuate nucleus nueropeptide Y and pro-opiomelanocortin mRNA in non-coma hypoglycemia. Diabetes 49, 820-826. (Pubitemid 30339999)
122. Tkacs, N.C., Pan, Y., Raghupathi, R., Dunn-Meynell, A., Levin, B., 2005. Cortical Fluoro-Jade staining and blunted adrenomedullary response to hypoglycemia after noncoma hypoglycemia in rats. J. Cereb. Blood Flow Metab. 25, 1645-1655. (Pubitemid 41683175)
123. Tupola, S., Salonen, I., Hannonen, R., et al., 2004. Comparison of regional cerebral perfusion, EEG and cognitive functions in type 1 diabetic children with and without severe hypoglycaemia. Eur. J. Pediatr. 163, 335-336. (Pubitemid 38725544)
124. Vannucci, R.C., Vannucci, S.J., 2001. Hypoglycemic brain injury. Semin. Neonatol. 6, 147-155. (Pubitemid 32705985)
125. Warren, R.E., Frier, B.M., 2005. Hypoglycaemia and cognitive function. Diabetes Obes. Metab. 7, 493-503. (Pubitemid 41150423)
126. Weinstock, R., Xing, D., Maahs, D., Michels, A., Rickels, M.R., Peters, A.L., Bergenstal, R., Harris, B., Dubose, S., Miller, K., Beck, R., 2013. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: Results from the T1D exchange clinic registry. J. Clin. Endocrinol. Metabol. 10, 1-10.
127. White, N., Skor, D., Cryer, P., Levandoski, L., Bier, D., Santiago, J., 1983. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N. Engl. J. Med. 308, 485-491. (Pubitemid 13195475)
128. Widom, B., Simonson, D., 1990. Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus. Ann. Intern. Med. 112, 904-912. (Pubitemid 20193674)
129. Wieloch, T., 1985. Hypoglycemia-induced neuronal damage prevented by an N-Methyl-D-Aspartate antagonist. Science 230, 681-683. (Pubitemid 16190965)
130. Wirsen, A., Tallrot, G., Lindgren, M., Agardh, C.D., 1992. Neuropsychological performance differs between type 1 diabetic and normal men during insulin-induced hypoglycaemia. Diabetes Med. 9, 156-165.
131. Won, S.J., Jang, B.G., Yoo, B.H., Sohn, M., Lee, M.W., Choi, B.Y., Kim, J.H., Song, H.K., Suh, S.W., 2012a. Prevention of acute/severe hypoglycemia-induced neuron death by lactate administration. J. Cereb. Blood Flow Metab. 32, 1086-1096.
132. Won, S.J., Yoo, B.H., Kauppinen, T.M., Choi, B.Y., Kim, J.H., Jang, B.G., Lee, M.W., Sohn, M., Liu, J., Swanson, R.A., Suh, S.W., 2012b. Recurrent/moderate hypoglycemia induces hippocampal dendritic injury, microglial activation, and cognitive impairment in diabetic rats. J. Neuroinflammation 9, 1-45.
133. Won, S., Kim, J., Yoo, B., Sohn, M., Kauppinen, T., Park, M., Kwon, H., Liu, J., Suh, S., 2012c. Prevention of hypoglycemia-induced neuronal death by minocycline. J. Neuroinflammation 9, 225.
134. Wrighten, S.A., Piroli, G., Grillo, C., Reagan, L., 2009. A look inside the diabetic brain: contributors to diabetes-induced brain aging. Biochim. Biophys. Acta 1792, 444-453.
135. Xu, C., Yogaratman, J., Lua, R., Naik, S., Khoo, C., Sasidaran, S., Sim, K., 2011. Persistent, severe hypoglycemia-induced organic brain syndrome with neurological sequelae: a case report. Gen. Hosp. Psichiatry 33, 411-412.
136. Yamada, K.A., Rensing, N., Izumi, Y., De Erausquin, G.A., Gazit, V., Dorsey, D.A., 2004. Repetitive hypoglycemia in young rats impairs hipocampal long-term potentiation. Pediatr. Res. 55, 372-379. (Pubitemid 38240812)
137. Yamada, K.A., Rensing, N., Thio, L., 2005. Ketogenic diet reduces hypoglycemia-induced neuronal death in young rats. Neurosci. Lett. 385, 210-214. (Pubitemid 40980402)
138. Yeh, H., Brown, T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y., Wilson, L., Harberl, E., Brick, J., Bass, E.B., Golden, S.H., 2012. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus. A systematic review and meta-analysis. Ann. Intern. Med. 157, 336-347.
139. Zhou, D., Qian, J., Chang, H., Xi, B., 2012. Pyruvate administered to newborn rats with insulin-induced hypoglycemic brain injury reduces neuronal death and cognitive impairment. Eur. J. Pediatr. 171, 103-109.